Hart S. Dengler
Research Subjects
Hart S. Dengler has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Adam R. Johnson
Department of Biochemical and Cellular Pharmacology
1 shared publication - Alexander R. Abbas
OMNI Bioinformatics, Genentech, South San Francisco, California 94080, USA
1 shared publication Alison Huynh
Necropsy, Genentech Inc., South San Francisco, CA 94080, USA
1 shared publicationBrendan J. Jenkins
Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia
1 shared publicationBrent S. McKenzie
Department of Translational Immunology, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA
1 shared publication- Cary D. Austin
Department of Pathology, Genentech, A Member of the Roche Group
1 shared publication
Latest Publications
- 12 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (627) , eabf8188
Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma
Bacterial-associated LPS drives oncostatin M–dependent airway inflammation and mucus hypersecretion in severe asthma.
- 12 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (627) , eabf8188
Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma
Bacterial-associated LPS drives oncostatin M–dependent airway inflammation and mucus hypersecretion in severe asthma.
- 21 November 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (468)
Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma
Inhalation of a Janus kinase 1 inhibitor suppressed lung inflammation without systemic side effects in rodent models of asthma.
- 21 November 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (468)
Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma
Inhalation of a Janus kinase 1 inhibitor suppressed lung inflammation without systemic side effects in rodent models of asthma.